Baxter's fourth quarter of 2025 saw total sales rise 8% year over year to $2.97 billion. The company's net income from continuing operations not in accordance with generally accepted accounting ...

Baxter calculates forward-looking non-GAAP financial measures based on forecasts that omit certain amounts that would be included in GAAP financial measures. For instance, forward-looking organic ...

Its final quarter of 2025 was mixed, with a notable whiff on earnings. On the plus side, it notched a convincing beat on revenue. Baxter's fourth quarter of 2025 saw total sales rise 8% year over year ...

Baxter International Inc. reported its fourth-quarter 2025 earnings, revealing earnings per share (EPS) of $0.44, missing the forecast of $0.54. Despite a revenue surprise of 4.58% with actual revenue ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Baxter International (NYSE:BAX) has announced a major organizational transformation ...

A McDowell County manufacturing facility has laid off approximately 90 employees. Baxter North Cove, a company that manufactures medical products such as intravenous solutions, has operated in ...

Feb 12 (Reuters) - Baxter (BAX.N), opens new tab forecast annual profit well below Wall Street expectations on Thursday, bracing for a year marked by uncertainty around its infusion pump business and ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Baxter CEO Andrew Hider is seeing his company take a ...

Good morning, ladies and gentlemen, and welcome to the Baxter International's Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded by Baxter ...

One of the conditions the Baxter City Council stated the Minnesota Department of Transportation needed to change to get the city's municipal consent for the buttonhook Highway 371 overpass design was ...

Baxter expects 2026 total sales growth to be flat to 1% on a reported basis, with organic sales growth approximately flat. The company projects an adjusted EPS of $1.85 to $2.05 per diluted share for ...